Copyright Reports & Markets. All rights reserved.

Global Kidney/Renal Fibrosis Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Kidney/Renal Fibrosis Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Angiotensin II Receptor Blockers (ARBs)
      • 1.4.3 Angiotensin Converting Enzyme (ACE) Inhibitors
      • 1.4.4 Pirfenidone
      • 1.4.5 Renin Inhibitors
      • 1.4.6 Vasopeptidase Inhibitors
    • 1.5 Market by Application
      • 1.5.1 Global Kidney/Renal Fibrosis Treatment Market Share by Application (2019-2025)
      • 1.5.2 Commercial/Private Hospitals
      • 1.5.3 Public Health Hospitals
      • 1.5.4 Clinics
      • 1.5.5 Home Treatment
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Kidney/Renal Fibrosis Treatment Market Size
    • 2.2 Kidney/Renal Fibrosis Treatment Growth Trends by Regions
      • 2.2.1 Kidney/Renal Fibrosis Treatment Market Size by Regions (2019-2025)
      • 2.2.2 Kidney/Renal Fibrosis Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Kidney/Renal Fibrosis Treatment Market Size by by Players
      • 3.1.1 Global Kidney/Renal Fibrosis Treatment Revenue by by Players (2014-2019)
      • 3.1.2 Global Kidney/Renal Fibrosis Treatment Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Kidney/Renal Fibrosis Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Kidney/Renal Fibrosis Treatment Key Players Head office and Area Served
    • 3.3 Key Players Kidney/Renal Fibrosis Treatment Product/Solution/Service
    • 3.4 Date of Enter into Kidney/Renal Fibrosis Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Kidney/Renal Fibrosis Treatment Market Size by Type (2014-2019)
    • 4.2 Global Kidney/Renal Fibrosis Treatment Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
    • 5.2 Kidney/Renal Fibrosis Treatment Key Players in North America
    • 5.3 North America Kidney/Renal Fibrosis Treatment Market Size by Type
    • 5.4 North America Kidney/Renal Fibrosis Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
    • 6.2 Kidney/Renal Fibrosis Treatment Key Players in Europe
    • 6.3 Europe Kidney/Renal Fibrosis Treatment Market Size by Type
    • 6.4 Europe Kidney/Renal Fibrosis Treatment Market Size by Application

    7 China

    • 7.1 China Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
    • 7.2 Kidney/Renal Fibrosis Treatment Key Players in China
    • 7.3 China Kidney/Renal Fibrosis Treatment Market Size by Type
    • 7.4 China Kidney/Renal Fibrosis Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
    • 8.2 Kidney/Renal Fibrosis Treatment Key Players in Japan
    • 8.3 Japan Kidney/Renal Fibrosis Treatment Market Size by Type
    • 8.4 Japan Kidney/Renal Fibrosis Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
    • 9.2 Kidney/Renal Fibrosis Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Type
    • 9.4 Southeast Asia Kidney/Renal Fibrosis Treatment Market Size by Application

    10 India

    • 10.1 India Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
    • 10.2 Kidney/Renal Fibrosis Treatment Key Players in India
    • 10.3 India Kidney/Renal Fibrosis Treatment Market Size by Type
    • 10.4 India Kidney/Renal Fibrosis Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Kidney/Renal Fibrosis Treatment Market Size (2014-2019)
    • 11.2 Kidney/Renal Fibrosis Treatment Key Players in Central & South America
    • 11.3 Central & South America Kidney/Renal Fibrosis Treatment Market Size by Type
    • 11.4 Central & South America Kidney/Renal Fibrosis Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Galectin Therapeutics
      • 12.1.1 Galectin Therapeutics Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Kidney/Renal Fibrosis Treatment Introduction
      • 12.1.4 Galectin Therapeutics Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019))
      • 12.1.5 Galectin Therapeutics Recent Development
    • 12.2 Merck & Co.
      • 12.2.1 Merck & Co. Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Kidney/Renal Fibrosis Treatment Introduction
      • 12.2.4 Merck & Co. Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
      • 12.2.5 Merck & Co. Recent Development
    • 12.3 F. Hoffman-La Roche Ltd.
      • 12.3.1 F. Hoffman-La Roche Ltd. Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Kidney/Renal Fibrosis Treatment Introduction
      • 12.3.4 F. Hoffman-La Roche Ltd. Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
      • 12.3.5 F. Hoffman-La Roche Ltd. Recent Development
    • 12.4 Pfizer Inc.
      • 12.4.1 Pfizer Inc. Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Kidney/Renal Fibrosis Treatment Introduction
      • 12.4.4 Pfizer Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
      • 12.4.5 Pfizer Inc. Recent Development
    • 12.5 InterMune Inc.
      • 12.5.1 InterMune Inc. Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Kidney/Renal Fibrosis Treatment Introduction
      • 12.5.4 InterMune Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
      • 12.5.5 InterMune Inc. Recent Development
    • 12.6 ProMetic Life-Sciences Inc.
      • 12.6.1 ProMetic Life-Sciences Inc. Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Kidney/Renal Fibrosis Treatment Introduction
      • 12.6.4 ProMetic Life-Sciences Inc. Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
      • 12.6.5 ProMetic Life-Sciences Inc. Recent Development
    • 12.7 La Jolla Pharmaceutical Company
      • 12.7.1 La Jolla Pharmaceutical Company Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Kidney/Renal Fibrosis Treatment Introduction
      • 12.7.4 La Jolla Pharmaceutical Company Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
      • 12.7.5 La Jolla Pharmaceutical Company Recent Development
    • 12.8 Genzyme Corporation
      • 12.8.1 Genzyme Corporation Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Kidney/Renal Fibrosis Treatment Introduction
      • 12.8.4 Genzyme Corporation Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
      • 12.8.5 Genzyme Corporation Recent Development
    • 12.9 BioLine Rx Ltd
      • 12.9.1 BioLine Rx Ltd Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Kidney/Renal Fibrosis Treatment Introduction
      • 12.9.4 BioLine Rx Ltd Revenue in Kidney/Renal Fibrosis Treatment Business (2014-2019)
      • 12.9.5 BioLine Rx Ltd Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Kidney/Renal fibrosis, defined as an aberrant wound healing process in response to chronic injury, is characterized by the progressive and persistent accumulation of extracellular matrix components (ECM) in the kidney, ultimately leading to renal failure.
      In 2018, the global Kidney/Renal Fibrosis Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Kidney/Renal Fibrosis Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Kidney/Renal Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      Galectin Therapeutics
      Merck & Co.
      F. Hoffman-La Roche Ltd.
      Pfizer Inc.
      InterMune Inc.
      ProMetic Life-Sciences Inc.
      La Jolla Pharmaceutical Company
      Genzyme Corporation
      BioLine Rx Ltd

      Market segment by Type, the product can be split into
      Angiotensin II Receptor Blockers (ARBs)
      Angiotensin Converting Enzyme (ACE) Inhibitors
      Pirfenidone
      Renin Inhibitors
      Vasopeptidase Inhibitors

      Market segment by Application, split into
      Commercial/Private Hospitals
      Public Health Hospitals
      Clinics
      Home Treatment

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Kidney/Renal Fibrosis Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Kidney/Renal Fibrosis Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Kidney/Renal Fibrosis Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
      Buy now